Share This On:
(AP) — The maker of a permanent contraceptive implant subject to thousands of injury reports from women and repeated safety restrictions by regulators says it will stop selling the device in the US.
Bayer said Friday the safety of its Essure implant has not changed and it will stop selling the device at the end of the year due to weak sales. Last year, Bayer stopped selling the device in Europe.
The Food and Drug Administration has placed multiple restrictions on the device following patient reports of pain, bleeding, allergic reactions and cases where the implant punctured the uterus or shifted out of place.
In May, the FDA said doctors must show women a checklist of the device’s risks before implanting it.
More than 16,000 US women are suing Bayer over Essure.
More International News Stories
- Over 5,000 new cases of coronavirus confirmed in single day in China February 14, 2020
- Virus infects more than 1,700 health workers in China, 6 die February 14, 2020
- Killer asteroid to miss earth by 3.6 million miles on Saturday February 14, 2020
- UN: Congo’s ebola outbreak slows but still global emergency February 13, 2020
- Fall in new cases raises hope in virus outbreak in China February 13, 2020
- Coronavirus is a bigger threat than terrorism: World Health Organization February 12, 2020
- Pope rejects a proposal to allow married priests in the Amazon February 12, 2020